RIDGELINE THERAPEUTICS LLC

Home | Ridgeline

Houston, United States · Founded 2018

Headquarters
Houston, Texas
Employees
1–10
Founded
2018
Business Model
B2B
Last Round
GrantSep 2018
Rounds
2

About

Ridgeline Therapeutics is a Houston-based biotech company developing first-in-class small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) to reverse age-related muscle weakness, Type 2 diabetes, obesity, muscular dystrophies, and kidney disease. The company's technology was invented at the University of Texas Medical Branch and is backed by NIH SBIR funding.

Summary

RIDGELINE THERAPEUTICS LLC is a Biotech company based in Houston, United States, founded in 2018. Its most recent funding was a Grant round in Sep 2018. Investors include Department of Health and Human Services.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSep 2018

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RIDGELINE THERAPEUTICS LLC on Indexed.vc
<a href="https://indexed.vc/companies/ridgeline-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/ridgeline-therapeutics-llc" alt="RIDGELINE THERAPEUTICS LLC on Indexed.vc" width="260" height="76" /></a>